Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The bone‐remodeling transient: Implications for the interpretation of clinical studies of bone mass change

The bone‐remodeling transient: Implications for the interpretation of clinical studies of bone... A computer simulation of the bone‐remodeling transient is described, in which the focus is explicitly on changes in clinically measurable bone mass (or density). Based upon quantitative remodeling data accumulated by histomorphometry and calcium tracer kinetics, the simulation shows that much of the apparent gain in bone produced by several agents currently employed to treat osteoporosis can be explained as a remodeling transient rather than as a fundamental alteration of remodeling balance. Even gains as large as 30% or more can be produced by nothing more than the remodeling transient under certain plausible combinations of basal remodeling rate, remodeling period, and degree of bone loss. The simulation further highlights the importance, in evaluating bone‐active agents, of separating the response across the first remodeling period from bone changes that may ensue thereafter. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Bone and Mineral Research Oxford University Press

The bone‐remodeling transient: Implications for the interpretation of clinical studies of bone mass change

Journal of Bone and Mineral Research , Volume 9 (10): 9 – Oct 1, 1994

Loading next page...
 
/lp/oxford-university-press/the-bone-remodeling-transient-implications-for-the-interpretation-of-PtLg7bFqDx

References (36)

Publisher
Oxford University Press
Copyright
Copyright © 1994 ASBMR
ISSN
0884-0431
eISSN
1523-4681
DOI
10.1002/jbmr.5650091003
Publisher site
See Article on Publisher Site

Abstract

A computer simulation of the bone‐remodeling transient is described, in which the focus is explicitly on changes in clinically measurable bone mass (or density). Based upon quantitative remodeling data accumulated by histomorphometry and calcium tracer kinetics, the simulation shows that much of the apparent gain in bone produced by several agents currently employed to treat osteoporosis can be explained as a remodeling transient rather than as a fundamental alteration of remodeling balance. Even gains as large as 30% or more can be produced by nothing more than the remodeling transient under certain plausible combinations of basal remodeling rate, remodeling period, and degree of bone loss. The simulation further highlights the importance, in evaluating bone‐active agents, of separating the response across the first remodeling period from bone changes that may ensue thereafter.

Journal

Journal of Bone and Mineral ResearchOxford University Press

Published: Oct 1, 1994

There are no references for this article.